Cite
Carew JS, Espitia CM, Zhao W, et al. Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas. Oncotarget. 2017;8(49):86769-86783doi: 10.18632/oncotarget.21423.
Carew, J. S., Espitia, C. M., Zhao, W., Mita, M. M., Mita, A. C., & Nawrocki, S. T. (2017). Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas. Oncotarget, 8(49), 86769-86783. https://doi.org/10.18632/oncotarget.21423
Carew, Jennifer S, et al. "Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas." Oncotarget vol. 8,49 (2017): 86769-86783. doi: https://doi.org/10.18632/oncotarget.21423
Carew JS, Espitia CM, Zhao W, Mita MM, Mita AC, Nawrocki ST. Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas. Oncotarget. 2017 Sep 30;8(49):86769-86783. doi: 10.18632/oncotarget.21423. eCollection 2017 Oct 17. PMID: 29156834; PMCID: PMC5689724.
Copy
Download .nbib